Suppr超能文献

原发性腹膜后肿瘤(作者译)

[Primary retroperitoneal tumours (author's transl)].

作者信息

Daniels V, Brünner H

出版信息

Dtsch Med Wochenschr. 1979 Aug 24;104(34):1202-7. doi: 10.1055/s-0028-1129071.

Abstract

Mean duration from symptoms to diagnosis in 87 patients with primary retroperitoneal tumour was 4.8 months for malignant tumour (67 patients), 18.1 months for benign tumour (20). The cardinal symptoms were palpable abdominal mass (68%), feeling of fullness and nausea (64%), as well as ill-defined abdominal pain (55%). Radiological diagnosis, especially selective angiography, provided important pointers to the global diagnosis of "retroperitoneal tumour". Small-needle biopsy, guided by ultrasound, has now become available in the pre-operative diagnosis of the type and malignancy of these tumours. After radical resection of 30 malignant tumours there was a mean survival time of, so far, 30.2 months. Results were worse with palliative malignant-tumour removal in 25 patients, at an average of 17.3 months. Survival time was only 4.8 months for 29 patients declared inoperable. In individual instances cytostatic treatment achieved an increase in survival time of up to 12 years.

摘要

87例原发性腹膜后肿瘤患者中,恶性肿瘤(67例)从出现症状到确诊的平均时间为4.8个月,良性肿瘤(20例)为18.1个月。主要症状为可触及的腹部肿块(68%)、饱胀感和恶心(64%),以及定位不清的腹痛(55%)。放射学诊断,尤其是选择性血管造影,为“腹膜后肿瘤”的整体诊断提供了重要线索。在超声引导下的细针活检现已可用于这些肿瘤的类型和恶性程度的术前诊断。30例恶性肿瘤根治性切除术后,到目前为止平均生存时间为30.2个月。25例姑息性切除恶性肿瘤患者的结果较差,平均为17.3个月。29例被宣布无法手术的患者生存时间仅为4.8个月。在个别情况下,细胞抑制治疗使生存时间延长至12年。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验